THE DUAL SYK/JAK INHIBITOR CERDULATINIB DEMONSTRATES RAPID...

Hematological Oncology 2017 / 06 Vol. 35

THE DUAL SYK/JAK INHIBITOR CERDULATINIB DEMONSTRATES RAPID TUMOR RESPONSES IN a PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL MALIGNANCIES

Hamlin, P.A., Farber, C.M., Fenske, T.S., Khatcheressian, J.L., Miller, C.B., Munoz, J., Patel, M.R., Schreeder, M.T., Smith, S.M., Stevens, D.A., Pandey, A., Birrell, M.R., Leeds, J.M., Wang, Y.L., C
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2437_61
Date:
June, 2017
File:
PDF, 71 KB
english, 2017
Conversion to is in progress
Conversion to is failed